Favorable Media Coverage Somewhat Unlikely to Affect Kindred Healthcare (KND) Stock Price

Media stories about Kindred Healthcare (NYSE:KND) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Kindred Healthcare earned a media sentiment score of 0.26 on Accern’s scale. Accern also gave news coverage about the health services provider an impact score of 45.5188915861012 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the news stories that may have effected Accern’s analysis:

Shares of Kindred Healthcare (KND) opened at $7.15 on Thursday. The company has a current ratio of 1.55, a quick ratio of 1.53 and a debt-to-equity ratio of 6.22. Kindred Healthcare has a 1 year low of $5.50 and a 1 year high of $11.90. The company has a market cap of $625.91, a price-to-earnings ratio of 36.00, a price-to-earnings-growth ratio of 3.56 and a beta of 1.21.

Kindred Healthcare (NYSE:KND) last announced its earnings results on Monday, November 6th. The health services provider reported ($0.11) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.19) by $0.08. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.44 billion. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The company’s revenue for the quarter was down 5.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.05 EPS. equities research analysts forecast that Kindred Healthcare will post 0.27 earnings per share for the current fiscal year.

Several brokerages have recently commented on KND. Stifel Nicolaus raised Kindred Healthcare from a “sell” rating to a “hold” rating and set a $7.00 target price for the company in a research report on Monday, November 20th. Deutsche Bank reissued a “hold” rating and set a $9.00 price objective (down previously from $10.00) on shares of Kindred Healthcare in a research report on Monday, September 18th. Zacks Investment Research lowered Kindred Healthcare from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Mizuho restated a “neutral” rating and set a $7.50 target price (down from $8.00) on shares of Kindred Healthcare in a report on Tuesday, October 10th. Finally, ValuEngine upgraded Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, November 9th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $8.86.

WARNING: “Favorable Media Coverage Somewhat Unlikely to Affect Kindred Healthcare (KND) Stock Price” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://ledgergazette.com/2017/12/07/kindred-healthcare-knd-given-daily-media-sentiment-score-of-0-26.html.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Insider Buying and Selling by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply